VSIQQ 120MG/ML INTRAVITREAL VIAL 0.23 ML
BROLUCIZUMAB
Old price: 8٬600٫000 (EGP)
76٫000 (EGP)
1. Treatment of neovascular (wet) age-related macular degeneration (AMD) 2. Reduction of choroidal neovascularization 3. Improvement in visual acuity 4. Maintenance of retinal anatomy 5. Reduction of central subfield thickness
